.AstraZeneca execs claim they are actually "certainly not worried" that the failure of tozorakimab i...
.Invite to recently's Chutes & Ladders, our summary of significant management hirings, firings as...
.After showing plans to reach the U.S. public markets less than a month back, Zenas Biopharma as wel...
.Psyence Biomedical is spending $500,000 in reveals to obtain fellow psilocybin-based biotech Clairv...